AIC
ADVM

AWM Investment Company’s Adverum Biotechnologies ADVM Stock Holding History

AWM Investment Company’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,000
Closed -$500K – 90
2017
Q2 		$500K Hold
20,000
– – 0.09% 83
2017
Q1 		$540K Buy
+20,000
New +$569K 0.1% 85

Other funds holding ADVM

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

AWM Investment Company's ADVM Position: Q3 2017 in Review

AWM Investment Company sold out of Adverum Biotechnologies (ADVM) in Q3 2017, closing a stake of 20,000 shares — an estimated $500K sold.

AWM Investment Company first reported a position in ADVM in Q1 2017 and held it in 2 quarters. The position peaked at $540K in Q1 2017. 58 funds tracked by Wall St. Rank hold ADVM as of Q3 2017.

  • AWM Investment Company reported no remaining Adverum Biotechnologies position as of Q3 2017 after selling out during the quarter.
  • AWM Investment Company sold 20,000 Adverum Biotechnologies shares in Q3 2017, an estimated $500K.
  • AWM Investment Company first reported a position in Adverum Biotechnologies in Q1 2017 and held it in 2 quarters.
  • AWM Investment Company's Adverum Biotechnologies position peaked at $540K in Q1 2017.
  • 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2017.

Based on AWM Investment Company's 13F filing for Q3 2017, filed 14 Nov 2017.